If you experience inadequate response after 1216 weeks at a therapeutic maintenance dose (typically 1015 mg weekly) despite good adherence and lifestyle modifications, consult your healthcare provider to assess for secondary causes, verify proper administration technique, and consider dose optimization or alternative treatment strategies
Thankfully, though, this kind of choice is far from inevitable
Wegovy and other semaglutide medications have experienced periods of limited availability, making it difficult for some patients to obtain their prescriptions.[5] During the height of the shortages, healthcare providers sometimes had to adjust dosing strategies to help patients maintain treatment.[6] Novo Nordisk, the manufacturer of Wegovy and Ozempic, has reported efforts to increase production and improve supply, though demand may still exceed availability in some areas.[7] Compounded semaglutide may be more readily available in some cases and may be less expensive for certain patients
Weight loss reduces mechanical loading on joints , which decreases pain from osteoarthritis and other degenerative conditions
T.KhalidU.et al (2023)